Osteoporosis risk screening for women in a community pharmacy

被引:14
|
作者
Liu, Yifei [1 ]
Nevins, Justin C. [2 ]
Carruthers, Kara M. [3 ]
Doucette, William R. [1 ]
McDonough, Randal P. [4 ]
Pan, Xiaoyun [1 ]
机构
[1] Univ Iowa, Coll Pharm, Program Pharmaceut Socioecon, Iowa City, IA 52242 USA
[2] Univ Iowa, Inpatient Care Units, Iowa City, IA 52242 USA
[3] Main Locust Pharm Clin & Med Supply, Clin Serv, Iowa City, IA USA
[4] Towncrest Pharm, Iowa City, IA USA
关键词
osteoporosis; bone mineral density screening; community and ambulatory pharmacy; cost analysis; business models; pharmacy services;
D O I
10.1331/JAPhA.2007.05107
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To describe the development, implementation, and financial aspects of a sustainable osteoporosis screening service in a community pharmacy and report osteoporosis risk factors for women screened during the 48 months in which the screening service was in operation. Setting: An independent community pharmacy (Main at Locust Pharmacy Clinic) in Davenport, Iowa, beginning in 1999. Practice description: The osteoporosis screening service was provided by a staff pharmacist, a pharmacy resident, or a combination of a pharmacist and a resident. The service included use of the Hologic Sahara Bone Sonometer at the heel and education of the patient. Patient education consisted of a discussion of screening results, an overview of osteoporosis, and recommendations to address risk factors. Practice innovation: For patients who received osteoporosis screening, an overall cumulative risk score and a cumulative modifiable risk score were calculated. Patients were identified as having high (T-score <=-1), moderate (-1 < T-score < 0), or low (T-score >= 0) risk. An analysis was performed to determine the net financial gain or loss of osteoporosis screening. Intervention: Osteoporosis screening service. Main outcome measures: T-score, overall cumulative risk score, cumulative modifiable risk score, and net financial gain of service. Results: A total of 444 women received the osteoporosis screening service during 48 months. More than 90% of the women had an overall cumulative risk score of at least 3, and 83.3% had at least one modifiable risk factor. According to the bone density tests, about 58% of the women were at high risk for osteoporosis and 25.7% were at moderate risk. The service had a net gain if provided by a pharmacist ($4,823.72), a resident ($8,153.72), or a combination of a pharmacist and a resident ($6,488.72). Conclusion: This pharmacy-based osteoporosis screening service effectively identified patients at risk for osteoporosis and was sustainable for 48 months. Other community pharmacies are encouraged to offer similar services.
引用
收藏
页码:521 / U121
页数:13
相关论文
共 50 条
  • [1] Women's Attitudes and Health Beliefs toward Osteoporosis Screening in a Community Pharmacy
    Deo, Priyanka
    Nayak, Rajesh
    Rajpura, Jigar
    [J]. JOURNAL OF OSTEOPOROSIS, 2013, 2013
  • [2] AN IMPLEMENTATION SCIENCE APPROACH TO COMMUNITY PHARMACY OSTEOPOROSIS SCREENING
    Phuong, J.
    Moles, R.
    Carter, S.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S495 - S495
  • [3] Detection of osteoporosis risk factors in the community pharmacy setting
    Tadic, I
    Tasic, L.
    Lazic, C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (04) : 717 - 717
  • [4] Identification of at-risk women for osteoporosis screening
    Weinstein, L
    Ullery, B
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (03) : 547 - 549
  • [5] Knowledge and attitudes of women under treatment of osteoporosis at community pharmacy setting
    Ozkan, O.
    Gulec, O.
    Torun, B.
    Soylemez, S. L.
    Sancar, M.
    Okuyan, B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 300 - 300
  • [6] Pilot programme for screening perimenopausal women for cardiovascular risk from community pharmacy: MENOVASC Project
    Palazon-Palazon, Andrea
    Sanchez-Martinez, Diego Pablo
    [J]. FARMACEUTICOS COMUNITARIOS, 2023, 15 (03): : 17 - 24
  • [7] Bone density screening and osteoporosis risk in women with disabilities
    Smeltzer, SC
    Zimmerman, V
    Fernandes, L
    [J]. NEUROLOGY, 2001, 56 (08) : A363 - A363
  • [8] Global cardiovascular risk screening - A community pharmacy based study
    Martins, S. O.
    Cabrita, J.
    Caramona, M.
    Vanmil, J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S273 - S273
  • [9] Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse
    Cochran, Gerald
    Rubinstein, Jessica
    Bacci, Jennifer L.
    Ylioja, Thomas
    Tarter, Ralph
    [J]. JOURNAL OF ADDICTION MEDICINE, 2015, 9 (05) : 411 - 416
  • [10] EPIDEMIOLOGICAL PROFILE OF ELDERLY WOMEN WITH OSTEOPOROSIS AND RISK FOR OSTEOPOROSIS: SCREENING IN NURSING PRACTICE
    Lindolpho, Mirian da Costa
    de Mello, Liliane Pinheiro
    Cavalcanti Valente, Geilsa Soraia
    Chaves Sa, Selma Petra
    Gomes, Vanice
    Chrisostimo, Miriam Marinho
    [J]. REVISTA DE PESQUISA-CUIDADO E FUNDAMENTAL ONLINE, 2011, 3 (04): : 2509 - 2517